Vitamin D3 As Potential Treatment Adjuncts for COVID-19

Overview

Journal Nutrients

Date 2020 Nov 18

PMID 33202670

Citations 26

Authors

Lucia Malaguarnera

Affiliations

Soon will be listed here.

Abstract

Severe acute respiratory syndrome coronavirus type (SARS-CoV2, also known as COVID-19), which is the latest pandemic infectious disease, constitutes a serious risk to human health. SARS-CoV2 infection causes immune activation and systemic hyperinflammation which can lead to respiratory distress syndrome (ARDS). ARDS victims are characterized by a significant increase in IL-6 and IL-1. Macrophage activation, associated with the "cytokine storm", promotes the dysregulation of the innate immunity. So far, without vaccines or specific therapy, all efforts to design drugs or clinical trials are worthwhile. Vitamin D and its receptor vitamin D receptor (VDR) exert a critical role in infections due to their remarkable impact on both innate and adaptive immune responses and on the suppression of the inflammatory process. The protective properties of vitamin D supplementation have been supported by numerous observational studies and by meta-analysis of clinical trials for prevention of viral acute respiratory infection. In this review, we compare the mechanisms of the host immune response to SARS-CoV2 infection and the immunomodulatory actions that vitamin D exerts in order to consider the preventive effect of vitamin D supplementation on SARS-CoV2 viral infection.

Citing Articles

Role of innate immunity in SARS-CoV-2 infection.

Wang Z, Cheng F, Xu Y, Li X, Meng S Biosaf Health. 2025; 5(5):280-288.

PMID: 40078906 PMC: 11894970. DOI: 10.1016/j.bsheal.2023.08.005.

The Power of Vitamin D: Is the Future in Precision Nutrition through Personalized Supplementation Plans?.

Mavar M, Soric T, Bagaric E, Saric A, Matek Saric M Nutrients. 2024; 16(8).

PMID: 38674867 PMC: 11054101. DOI: 10.3390/nu16081176.

Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection.

Wu J, Liu M, Hsu W, Tsai Y, Liu T, Huang P Eur J Nutr. 2023; 63(2):613-622.

PMID: 38112761 DOI: 10.1007/s00394-023-03298-3.

Comparison of Vitamin D and Resveratrol Performances in COVID-19.

Russo C, Valle M, Malaguarnera L, Romano I, Malaguarnera L Nutrients. 2023; 15(11).

PMID: 37299603 PMC: 10255599. DOI: 10.3390/nu15112639.

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics.

Cusato J, Manca A, Palermiti A, Mula J, Costanzo M, Antonucci M Antioxidants (Basel). 2023; 12(5).

PMID: 37237997 PMC: 10215473. DOI: 10.3390/antiox12051133.

References

Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C . Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res. 2005; 21(1):37-47. DOI: 10.1359/JBMR.050908. View

Overbergh L, Stoffels K, Waer M, Verstuyf A, Bouillon R, Mathieu C . Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J Clin Endocrinol Metab. 2006; 91(9):3566-74. DOI: 10.1210/jc.2006-0678. View

Chen L, Yang X, Nissen D, Chen Y, Wang L, Wang J . Dysregulated renin-angiotensin system contributes to acute lung injury caused by hind-limb ischemia-reperfusion in mice. Shock. 2013; 40(5):420-9. DOI: 10.1097/SHK.0b013e3182a6953e. View

Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L . Vitamin D3: a helpful immuno-modulator. Immunology. 2011; 134(2):123-39. PMC: 3194221. DOI: 10.1111/j.1365-2567.2011.03482.x. View

Tan W, Liao W, Zhou S, Mei D, Wong W . Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2017; 40:9-17. DOI: 10.1016/j.coph.2017.12.002. View

Zhang M, Dong M, Liu W, Wang L, Luo Y, Li Z . 1α,25-dihydroxyvitamin D3 ameliorates seawater aspiration-induced acute lung injury via NF-κB and RhoA/Rho kinase pathways. PLoS One. 2014; 9(8):e104507. PMC: 4132109. DOI: 10.1371/journal.pone.0104507. View

Sly L, Lopez M, Nauseef W, Reiner N . 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem. 2001; 276(38):35482-93. DOI: 10.1074/jbc.M102876200. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Shang J, Wan Y, Liu C, Yount B, Gully K, Yang Y . Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog. 2020; 16(3):e1008392. PMC: 7082060. DOI: 10.1371/journal.ppat.1008392. View

10.

Hata M, Takahara S, Tsuzaki H, Ishii Y, Nakata K, Akagawa K . Expression of Th2-skewed pathology mediators in monocyte-derived type 2 of dendritic cells (DC2). Immunol Lett. 2009; 126(1-2):29-36. DOI: 10.1016/j.imlet.2009.07.008. View

11.

Li S, Wang C, Jou Y, Huang S, Hsiao L, Wan L . SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6. Int J Mol Sci. 2016; 17(5). PMC: 4881504. DOI: 10.3390/ijms17050678. View

12.

Ishii K, Takeuchi H, Fukunaga K, Hirano Y, Suda K, Hagiwara T . Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade. Exp Lung Res. 2015; 41(4):199-207. DOI: 10.3109/01902148.2014.993444. View

13.

Shi Y, Liu T, Fu J, Xu W, Wu L, Hou A . Vitamin D/VDR signaling attenuates lipopolysaccharide‑induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier. Mol Med Rep. 2015; 13(2):1186-94. PMC: 4732862. DOI: 10.3892/mmr.2015.4685. View

14.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

15.

Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

16.

Santos R, Sampaio W, Alzamora A, Motta-Santos D, Alenina N, Bader M . The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev. 2018; 98(1):505-553. PMC: 7203574. DOI: 10.1152/physrev.00023.2016. View

17.

Wang C, Horby P, Hayden F, Gao G . A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-473. PMC: 7135038. DOI: 10.1016/S0140-6736(20)30185-9. View

18.

Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I . The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004; 34(4):1068-76. DOI: 10.1002/eji.200324532. View

19.

Beilfuss A, Sowa J, Sydor S, Beste M, Bechmann L, Schlattjan M . Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 2014; 64(5):791-9. DOI: 10.1136/gutjnl-2014-307024. View

20.

Silberstein M . Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?. Med Hypotheses. 2020; 140:109767. PMC: 7177149. DOI: 10.1016/j.mehy.2020.109767. View